TherapeuticsMD, Inc.
TXMD
Nasdaq
Manufacturing
Chemicals
€ 2,03
▼
€ 0,02
(-0,98%)
Marktkapitalisatie: 23,50 M
Prijs
€ 2,03
Marktkapitalisatie
23,50 M
Dagbereik
€ 2,02 — € 2,06
52-Weeksbereik
€ 0,84 — € 2,95
Volume
4.911
Openen € 2,06
50D / 200D Gem.
€ 2,27
10,41% below
50D / 200D Gem.
€ 1,58
28,20% above
Koershistorie
Financiële Trends
No fundamental snapshot available yet.
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | 1,76 M | 1,30 M | 69,96 M | 86,95 M |
| Net Income | -569.000,0 | -2,18 M | -10,28 M | 112,00 M | -172,42 M |
| EPS (Diluted) | -0,05 | -0,19 | -0,98 | 11,96 | — |
| Gross Profit | — | — | 1,30 M | 68,57 M | 68,11 M |
| Operating Income | -4,39 M | -4,76 M | -8,52 M | 1,19 M | -139,77 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | — | — | — | — | 7,09 M |
| SG&A Expenses | — | 4,74 M | — | — | — |
| D&A | 384.000,0 | 509.000,0 | 922.000,0 | 1,19 M | 4,09 M |
| Interest Expense | 8.000,0 | 9.500,0 | 300.000,0 | 36,07 M | 32,92 M |
| Income Tax | -31.000,0 | -31.000,0 | -43.000,0 | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 37,66 M | 38,82 M | 43,31 M | 90,46 M | 169,47 M |
| Total Liabilities | 10,78 M | 11,45 M | 14,02 M | 55,32 M | 263,09 M |
| Shareholders' Equity | 26,88 M | 27,37 M | 29,29 M | 35,14 M | -93,62 M |
| Total Debt | — | — | — | 188,27 M | 188,27 M |
| Cash & Equivalents | — | 5,06 M | — | — | — |
| Current Assets | 14,45 M | 12,26 M | 11,80 M | 55,35 M | 119,47 M |
| Current Liabilities | 4,79 M | 5,17 M | 6,85 M | 46,84 M | 252,89 M |
{"event":"ticker_viewed","properties":{"ticker":"TXMD","listing_kind":"stock","pathname":"/stocks/txmd","exchange":"Nasdaq","country":"US"}}